Avenzo

formerly Avenzo Therapeutics

Developing the next generation of oncology therapies for patients

San Diego, United States · Founded 2022 · $832.0M raised

Employees
1–10
Founded
2022
Business Model
B2B
Total Funding
$832.0M
Last Round
$60.0M Series BSep 2025
Rounds
4

About

Avenzo Therapeutics is a clinical-stage biopharmaceutical company focused on developing next-generation small-molecule and antibody-drug conjugate (ADC) therapies for oncology. Founded in 2022 by veterans of Turning Point Therapeutics (acquired by Bristol Myers Squibb for $4.1B in 2022), the San Diego-based company targets cancers with high unmet medical needs. The company has raised over $60M in Series B financing with backing from OrbiMed, Foresite Capital, SR One, NEA, Lilly Asia Ventures, Sands Capital, and others.

Summary

Avenzo is a Biotech company based in San Diego, United States, founded in 2022. It has raised $832.0M in total across 4 rounds, most recently a $60.0M Series B round in Sep 2025. Investors include NEA, Deep Track Capital and Sofinnova Investments.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series BSeries BSep 2025
$60.0M

Sign up to see all 4 rounds

Series A through Series B — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Avenzo on Indexed.vc
<a href="https://indexed.vc/companies/avenzo"><img src="https://indexed.vc/api/badge/company/avenzo" alt="Avenzo on Indexed.vc" width="260" height="76" /></a>